# Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy

> **NCT00769093** · PHASE1 · TERMINATED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 6 (actual)

## Conditions studied

- Brain Neoplasms

## Interventions

- **DRUG:** Ferumoxytol

## Key facts

- **NCT ID:** NCT00769093
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Inadequate enrollment
- **Last updated:** 2017-04-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00769093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00769093, "Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00769093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*